We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
+15.07%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.65B
AUM Growth
+$134M
(+8.8%)
Cap. Flow
+$10.7M
Cap. Flow
% of AUM
0.65%
Top 10 Holdings %
Top 10 Hldgs %
48.84%
Holding
41
New
8
Increased
10
Reduced
10
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$65.6M |
| 2 |
ScottsMiracle-Gro
SMG
|
+$32.7M |
| 3 |
MSGN
MSG Networks Inc.
MSGN
|
+$31.7M |
| 4 |
Bank of America
BAC
|
+$29.6M |
| 5 |
Heron Therapeutics
HRTX
|
+$29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$60M |
| 2 |
DaVita
DVA
|
+$52.3M |
| 3 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$37.8M |
| 4 |
GoDaddy
GDDY
|
+$30.5M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$26.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 48.41% |
| 2 | Consumer Discretionary | 10.09% |
| 3 | Technology | 8.81% |
| 4 | Communication Services | 8.2% |
| 5 | Financials | 5.24% |
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q1 2018 Portfolio in Review
As of Q1 2018, Bridger Management held 41 positions worth $1.65B, up 8.8% from $1.52B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Bridger Management's Q1 2018 filing shows 8 new, 10 increased, 10 reduced and 4 closed positions. Its largest new stake was ScottsMiracle-Gro: 343,274 shares worth $29.4M. The largest sale was Nektar Therapeutics, an estimated $60M.
By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 46% a quarter earlier, followed by Consumer Discretionary and Technology.
- Bridger Management's largest Q1 2018 buy was ScottsMiracle-Gro: 343,274 shares worth $29.4M.
- Bridger Management added most to Zimmer Biomet in Q1 2018, an estimated $65.6M increase.
- Bridger Management's biggest Q1 2018 reduction was Nektar Therapeutics, cutting an estimated $60M.
- Bridger Management fully exited DaVita in Q1 2018, selling an estimated $52.3M.
- Bridger Management's ten largest holdings make up 49% of its $1.65B portfolio in Q1 2018.
- Bridger Management opened 8 new positions and closed 4 in Q1 2018.
- Bridger Management's portfolio value rose 8.8% quarter-over-quarter to $1.65B.
Based on Bridger Management's 13F filing for Q1 2018, filed 15 May 2018.